Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Novavax Inc (NVAX) – Novavax Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Novavax (NVAX) trades at $8.04, up 0.88% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported a net loss of $187.50 million in 2024, though revenue grew to $682.16 million. Recent earnings beats and a projected net income of $440 million for 2025 signal potential improvement. However, negative shareholder equity and activist investor pressure from Shah Capital highlight ongoing challenges.
The outlook is mixed: strong analyst buy consensus (73.9%) and low valuation ratios (P/E 3.07) suggest upside, but cash flow volatility, high debt, and competitive vaccine market pose significant risks. Execution on profitability targets and successful R&D under new leadership are critical for sustained recovery.
Read full analysis

Key Stats

  • Market Cap
    $1.30B
  • Sector
    Health
  • 3M Drawdown
    -31.19%
  • Enterprise Value
    $816.81M
  • Dividend Yield
    -
  • Trading Activity
    3% Buy | 97% Sell
  • Typical Hold Time
    58 days
$8.04
52W Low: $5.95
07 May 2025
52W High: $11.19
26 Feb 2026

Novavax Inc (NVAX) is currently valued at a market capitalization of $1.30B, with an enterprise value of $816.81M. Over the past 52 weeks, Novavax Inc has traded between a low of $5.95 and a high of $11.19, highlighting its annual price range. Over the past three months, Novavax Inc has recorded a drawdown of -31.19%, reflecting recent price volatility. On average, investors hold Novavax Inc for approximately 58 days, indicating typical investor behavior on the platform.

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.


Technical Indicators
|
|
|
Overall Summary
Bearish (3)Neutral (7)Bullish (17)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $1.30B
  • Sector
    Health
  • 3M Drawdown
    -31.19%
  • Enterprise Value
    $816.81M
  • Dividend Yield
    -
  • Trading Activity
    3% Buy | 97% Sell
  • Typical Hold Time
    58 days
$8.04
52W Low: $5.95
07 May 2025
52W High: $11.19
26 Feb 2026

Novavax Inc (NVAX) is currently valued at a market capitalization of $1.30B, with an enterprise value of $816.81M. Over the past 52 weeks, Novavax Inc has traded between a low of $5.95 and a high of $11.19, highlighting its annual price range. Over the past three months, Novavax Inc has recorded a drawdown of -31.19%, reflecting recent price volatility. On average, investors hold Novavax Inc for approximately 58 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!